1. Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
   Miaowei Wu et al, 2020, Frontiers in Genetics CrossRef
2. Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy
   Xiao-Yu Li et al, 2022, Frontiers in Oncology CrossRef
3. NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer
   Wenxiu Liu et al, 2023, Disease Markers CrossRef
4. Nicotinamide N-methyltransferase (NNMT): A key enzyme in cancer metabolism and therapeutic target
   Wei-Dong Sun et al, 2024, International Immunopharmacology CrossRef
5. Proteomic Changes in the Monolayer and Spheroid Melanoma Cell Models of Acquired Resistance to BRAF and MEK1/2 Inhibitors
   Ramon Martinez et al, 2022, ACS Omega CrossRef
6. Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy
   Jie Liu et al, 2022, Frontiers in Immunology CrossRef
7. A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review)
   Benjamin Genenger et al, 2022, Discover Oncology CrossRef
8. Investigating Cutaneous Squamous Cell Carcinoma in vitro and in vivo: Novel 3D Tools and Animal Models
   Marika Quadri et al, 2022, Frontiers in Medicine CrossRef